FindTrial
Sign In

Correlation between iron deposition and oxidative stress in Parkinson's disease

Correlation between iron deposition and oxidative stress in Parkinson's disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200062099
Enrollment
Unknown
Registered
2022-07-22
Start date
2022-08-01
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Control group(tremor group, retardation and stiffness group, mixed group), experimental group (tremor group, retardation and stiffness group, mixed group):The experimental group will be treated with a

Sponsors

Yancheng No.1 People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: It was clinically diagnosed as Parkinson's disease / syndrome.

Exclusion criteria

Exclusion criteria: 1. Patients with cerebrovascular history, such as cerebral infarction, intracerebral hemorrhage and subarachnoid hemorrhage; 2. Patients with brain trauma and brain tumor history 3. Have a history of metabolic disease and mental illness; 4. Failing to sign informed consent or other neurological diseases.

Design outcomes

Primary

MeasureTime frame
Quantitative magnetic sensitivity examination of iron deposition value in the region of interest;microelement;ferritin;glutathione;uric acid;—

Countries

China

Contacts

Public ContactGuo Junhe

Yancheng No.1 people's Hospital

neuromed@163.com+86 15251131959

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026